Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.

ABSTRACT:

Background

As an ongoing worldwide health issue, Coronavirus disease 2019 (COVID-19) has been causing serious complications, including pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. However, there is no decisive treatment approach available for this disorder, which is primarily attributed to the large amount of inflammatory cytokine production. We aimed to identify the effects of Nano-curcumin on the modulation of inflammatory cytokines in COVID-19 patients.

Method

Forty COVID-19 patients and 40 healthy controls were recruited and evaluated for inflammatory cytokine expression and secretion. Subsequently, COVID-19 patients were divided into two groups: 20 patients receiving Nano-curcumin and 20 patients as the placebo group. The mRNA expressi

SUBMITTER: Valizadeh H 

PROVIDER: S-EPMC7574843 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature